Physician profile
Jonathan M Holmes
NPI 1063770709
$1,561.04
in general payments reported to CMS, 2019-2025
19 companies · $259 in 2025
The $259 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $53.71 · 2021: $156 · 2022: $104 · 2023: $178 · 2024: $223 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $534.93 | 2021-2025 | Azstarys |
| Pfizer INC. | $256.72 | 2019-2023 | |
| Ironshore Pharmaceuticals INC. | $205.57 | 2019 | |
| Biogen, INC. | $123.07 | 2019 | |
| Supernus Pharmaceuticals, INC. | $82.00 | 2023-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $76.91 | 2019-2024 | Gardasil, Gardasil 9, Rotateq |
| Sanofi Pasteur INC. | $55.78 | 2019-2024 | |
| Eyevance Pharmaceuticals LLC | $37.82 | 2021 | |
| Kaleo, INC. | $23.32 | 2021 | |
| Sanofi-Aventis U.S. LLC | $22.19 | 2024 | |
| Biomerieux INC | $20.33 | 2023 | |
| Ironwood Pharmaceuticals, INC | $20.20 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.74 | 2024 | Flumist Quadrivalent |
| Vertical Pharmaceuticals, LLC | $16.55 | 2025 | Relexxii |
| Tris Pharma INC | $15.92 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $13.51 | 2019 | |
| Seqirus USA INC | $13.35 | 2022 | |
| Medline Industries LP | $13.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.